diabetic%20retinopathy
DIABETIC RETINOPATHY
Diabetic retinopathy is an abnormality of the microvasculature of the retina that occurs to almost all patients with chronic diabetes mellitus.
It is one of the leading cause of blindness worldwide and principal cause of impaired vision in patients aged 25-75 years of age.
The abnormality causes microaneurysms, retinal hemorrhages, lipid exudates, macular edema & neovascular vessel growth that may lead to blindness.

Diabetic%20retinopathy Management

Follow Up

  • The follow-up interval recommended for the following DR severity:
    • 12 mths for normal or minimal NPDR
    • 6-12 mths for mild to moderate NPDR w/o CSME & inactive/involuted PDR w/o CSME
    • 2-4 mths for mild to moderate NPDR w/ CSME, severe NPDR, non-high-risk NPDR, high-risk NPDR & inactive/involuted PDR w/ CSME

Post-op Follow-up

  • A history of the changes on the following should be documented:
    • Symptoms
    • Glycemic status (HbA1c)
    • Systemic status (pregnancy, blood pressure, serum cholesterol, renal status)
  • Follow-up exam should include:
    • Visual acuity
    • Slit-lamp biomicroscopy w/ iris examination
    • Intraocular pressure (IOP) determination
    • Gonioscopy (if iris neovascularization is suspected or present or if IOP is increased)
    • Stereoscopic examination of the posterior pole after dilation of the pupils
    • Peripheral retina & vitreous examination, when indicated
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 3 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
3 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.